Abstract |
Hederagenin (He) is a novel triterpene template for the development of new antitumor compounds. In this study, 26 new He⁻pyrazine derivatives were synthetized in an attempt to develop potent antitumor agents; they were screened for in vitro cytotoxicity against tumor and non-tumor cell lines. The majority of these derivatives showed much stronger cytotoxic activity than He. Remarkably, the most potent was compound 9 (half maximal inhibitory concentration (IC50) was 3.45 ± 0.59 μM), which exhibited similar antitumor activities against A549 (human non-small-cell lung cancer) as the positive drug cisplatin (DDP; IC50 was 3.85 ± 0.63 μM), while it showed lower cytotoxicity on H9c2 (murine heart myoblast; IC50 was 16.69 ± 0.12 μM) cell lines. Compound 9 could induce the early apoptosis and evoke cell-cycle arrest at the synthesis (S) phase of A549 cells. Impressively, we innovatively introduced the method of cluster analysis modeled as partial least squares discriminant analysis (PLS-DA) into the structure⁻activity relationship (SAR) evaluation, and SAR confirmed that pyrazine had a profound effect on the antitumor activity of He. The present studies highlight the importance of pyrazine derivatives of He in the discovery and development of novel antitumor agents.
|
Authors | Kang Fang, Xiao-Hua Zhang, Yao-Tian Han, Gao-Rong Wu, De-Sheng Cai, Nan-Nan Xue, Wen-Bo Guo, Yu-Qin Yang, Meng Chen, Xin-Yu Zhang, Hui Wang, Tao Ma, Peng-Long Wang, Hai-Min Lei |
Journal | International journal of molecular sciences
(Int J Mol Sci)
Vol. 19
Issue 10
(Sep 30 2018)
ISSN: 1422-0067 [Electronic] Switzerland |
PMID | 30274380
(Publication Type: Journal Article)
|
Chemical References |
- Pyrazines
- Oleanolic Acid
- hederagenin
|
Topics |
- Apoptosis
(drug effects)
- Cell Cycle
(drug effects)
- Cell Death
- Cell Line, Tumor
- Cell Shape
(drug effects)
- Cluster Analysis
- Discriminant Analysis
- Drug Design
- Humans
- Inhibitory Concentration 50
- Least-Squares Analysis
- Oleanolic Acid
(analogs & derivatives, chemical synthesis, chemistry, toxicity)
- Principal Component Analysis
- Pyrazines
(chemical synthesis, chemistry, toxicity)
- Staining and Labeling
- Structure-Activity Relationship
|